Phosphate signaling in biomineralization
生物矿化中的磷酸盐信号传导
基本信息
- 批准号:9896296
- 负责人:
- 金额:$ 34.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistBindingBlood VesselsCalciumCartilageCell LineCell physiologyCellsChronicComplexCyclic AMPCyclic AMP-Dependent Protein KinasesDataDefectDentalDentinDevelopmentDiagnosisDiseaseExtracellular MatrixExtracellular Signal Regulated KinasesFluorescence Resonance Energy TransferFoundationsGene ExpressionGenesGeneticGenetic TranscriptionGoalsHomeostasisHypophosphatasiaHypophosphatemiaImageImpairmentIn VitroIsoenzymesKnockout MiceKnowledgeLifeMAPK3 geneMeasuresMediatingMediator of activation proteinMineralsMitogen-Activated Protein KinasesMolecularMolecular TargetMusMutateOdontoblastsOsteoblastsPTH genePathologicPathway interactionsPharmacologyPhosphotransferasesPhysiologicalPhysiologyProcessProtein Kinase CReceptor SignalingRoleSignal PathwaySignal TransductionSignaling MoleculeSpectroscopy, Fourier Transform InfraredTestingTissuesVesicleX-Ray Computed Tomographybasebiomineralizationbonecell growth regulationextracellularin vivoinhibitor/antagonistinorganic phosphatelive cell imagingmineralizationnovelosteogenicparathyroid hormone-related proteinprogenitorreceptorresponseskeletalsmall molecule inhibitortargeted treatmenttherapeutic target
项目摘要
Abstract
Inorganic phosphate (PO43-/Pi) is a critical regulator of the physiologic biomineralization process in skeletal and
dental tissues, and is a major contributing factor to pathologic mineralization of blood vessels. The central role
of Pi in biomineralization is underscored by a broad-range of mineralization defects in genetic and acquired
disorders affecting systemic Pi homeostasis (hyperphosphatemia and hypophosphatemia) and local/cellular Pi
availability (e.g. hypophosphatasia). Although it is well established now that Pi is a signaling molecule that can
change cellular physiology, the underlying molecular mechanisms by which Pi executes this function remain
largely unknown. This gap in our knowledge impedes development of targeted therapeutic approaches to
diseases caused by abnormal Pi availability. Our goal is to delineate the signaling cascade that regulates
biomineralization in response to extracellular Pi. We and others have shown that molecular interactions
upstream of Erk1/2 kinase are central to initiating the response to extracellular Pi in the majority of analyzed
cells. Our preliminary studies in cells producing mineralized extracellular matrix (osteogenic cells) identified a
molecular circuit, which is required for activation of Erk1/2 and mineralization-supporting functions in response
to Pi. First, our in vitro data show that osteogenic cells deficient in parathyroid hormone/parathyroid hormone
related protein receptor 1 (Pth1r) do not activate Erk1/2 under high Pi conditions and have significantly
impaired transcriptional response to Pi. Second, our data suggest that Pi-induced Erk1/2 activation and gene
expression are dependent on the protein kinase C (PKC). Furthermore, our data suggest that the cellular
response to Pi is enhanced by calcium (Ca2+). Based on these data we hypothesize that the Pi-induced
signaling cascade is integrated with the Pth1r-PKC-Erk1/2 pathway in osteogenic cells. To test this hypothesis
we will use in vitro and in vivo approaches focused on signaling in cells producing mineralized extracellular
matrix. In the Aim 1 of this project, we will define the molecular circuit of Pth1r-dependent activation of cellular
responses to Pi. In the Aim 2, we will determine the functional role of Pth1r in Pi signaling and Pi-regulated
mineralization in vivo. In the Aim 3, we will determine the role of Ca2+ in mineralization-supporting functions of
Pi signaling. By completing these Aims, will provide the first characterization of the Pi-induced signaling
cascade and identify molecular players required for initiation of cellular responses to Pi in osteogenic cells.
This will provide the foundation for identification of targets for pharmacological regulation of cellular sensitivity
to available Pi.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dobrawa Napierala其他文献
Dobrawa Napierala的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dobrawa Napierala', 18)}}的其他基金
Transcriptional Regulation of Dentin Mineralization
牙本质矿化的转录调控
- 批准号:
9038176 - 财政年份:2014
- 资助金额:
$ 34.03万 - 项目类别:
Transcriptional Regulation of Dentin Mineralization
牙本质矿化的转录调控
- 批准号:
8630687 - 财政年份:2014
- 资助金额:
$ 34.03万 - 项目类别:
Transcriptional Regulation of Dentin Mineralization
牙本质矿化的转录调控
- 批准号:
8836999 - 财政年份:2014
- 资助金额:
$ 34.03万 - 项目类别:
Role of Trps1 in endochondral bone formation
Trps1 在软骨内骨形成中的作用
- 批准号:
7866651 - 财政年份:2009
- 资助金额:
$ 34.03万 - 项目类别:
Role of Trps1 in Endochondral Bone Formation
Trps1 在软骨内骨形成中的作用
- 批准号:
8262423 - 财政年份:2009
- 资助金额:
$ 34.03万 - 项目类别:
Role of Trps1 in endochondral bone formation
Trps1 在软骨内骨形成中的作用
- 批准号:
8260988 - 财政年份:2009
- 资助金额:
$ 34.03万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel PPAR-gamma agonist selectively activate the ligand binding domain of PPAR-gamma and improve pathology and memory deficits in a 3xTg-Ad mouse model.
新型 PPAR-gamma 激动剂选择性激活 PPAR-gamma 的配体结合域,改善 3xTg-Ad 小鼠模型的病理和记忆缺陷。
- 批准号:
8890576 - 财政年份:2015
- 资助金额:
$ 34.03万 - 项目类别:
Atomic force microscopy study of structural and functional changes in membrane proteins upon agonist and antagonist binding
激动剂和拮抗剂结合后膜蛋白结构和功能变化的原子力显微镜研究
- 批准号:
BB/M503113/1 - 财政年份:2014
- 资助金额:
$ 34.03万 - 项目类别:
Training Grant
Agonist & Antagonist Activity and Binding on the TMD of hT1R3
激动剂
- 批准号:
7915254 - 财政年份:2009
- 资助金额:
$ 34.03万 - 项目类别:
Imaging Dopamine D2 Agonist Binding Sites in Cocaine Dependence with [11C]NPA
使用 [11C]NPA 对可卡因依赖中的多巴胺 D2 激动剂结合位点进行成像
- 批准号:
7782808 - 财政年份:2009
- 资助金额:
$ 34.03万 - 项目类别:
Imaging Dopamine D2 Agonist Binding Sites in Cocaine Dependence with [11C]NPA
使用 [11C]NPA 对可卡因依赖中的多巴胺 D2 激动剂结合位点进行成像
- 批准号:
7587737 - 财政年份:2009
- 资助金额:
$ 34.03万 - 项目类别:
Agonist & Antagonist Activity and Binding on the TMD of hT1R3
激动剂
- 批准号:
7725379 - 财政年份:2009
- 资助金额:
$ 34.03万 - 项目类别:
CONFORMATIONAL CHANGES AND MODE OF BINDING OF AGONIST TO ESTROGEN RECEPTOR
激动剂与雌激素受体的构象变化和结合方式
- 批准号:
7724014 - 财政年份:2008
- 资助金额:
$ 34.03万 - 项目类别:
Molecular determinants of melanocortin 4 receptor for selective agonist binding
黑皮质素 4 受体选择性激动剂结合的分子决定因素
- 批准号:
7669106 - 财政年份:2008
- 资助金额:
$ 34.03万 - 项目类别:
Agonist & Antagonist Activity and Binding on the TMD of hT1R3
激动剂
- 批准号:
7706667 - 财政年份:2008
- 资助金额:
$ 34.03万 - 项目类别:
Molecular recognition of barbiturate enantiomers in agonist binding site of nicotinic acetylcholine receptor
烟碱乙酰胆碱受体激动剂结合位点巴比妥酸盐对映体的分子识别
- 批准号:
19791062 - 财政年份:2007
- 资助金额:
$ 34.03万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




